IL1B and diabetes mellitus: Moreover, patients with MI seem to be at increased risk for recurrent major adverse cardiovascular events (MACEs), owing to their clinical characteristics, comorbidities, and biomarkers, such as elderly (especially older women) (11), diabetes mellitus (DM), heart failure (HF), renal dysfunction (12), and interleukin-1beta (13).